New treatments for CNV secondary to AMD: what evidence exists to supports a treatment recommendation?
Lanzetta
Paolo
P
D020256:Choroidal Neovascularization / Q000209:etiology* / Q000628:therapy*; D006801:Humans; D008268:Macular Degeneration / Q000150:complications*